Eton Pharmaceuticals, Inc. (ETON) vs Harrow, Inc. (HROW)
- Eton Pharmaceuticals, Inc. ETON 50.40 −1.81%
- Harrow, Inc. HROW 27.28 −5.11%
Eton Pharmaceuticals, Inc. and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. Eton Pharmaceuticals, Inc. is the larger, with a market value of $1.5B against $1.1B — 1.4× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Eton Pharmaceuticals, Inc. trades at 107×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 81.5% against 21.1%. Eton Pharmaceuticals, Inc. has the higher net margin (12.0% vs −13.5%) and the higher return on invested capital (21.4% vs −0.77%). Across the 19 metrics below, Eton Pharmaceuticals, Inc. leads on 12 and Harrow, Inc. on 7.
Valuation
Profitability
| Metric | ETON | HROW | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 57.87% | 73.28% | 53.94% |
| Operating margin | 15.44% | (1.00%) | 0.00% |
| Net margin | 12.02% | (13.51%) | 0.00% |
| Free cash flow margin | (7.94%) | (4.75%) | 0.00% |
| Return on equity | 35.97% | (116.07%) | (0.40%) |
| Return on assets | 11.67% | (9.77%) | (3.32%) |
| Return on invested capital | 21.39% | (0.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack